Blood Banking Devices Market, by Product (Blood Collection Devices, Blood Processing Devices, Blood Storage Devices), End- Users (Hospital, Academic Institutes, Independent Diagnostics Centers/Clinics, Blood Banks), Mode of Collection (Manual Blood Collection, Automated Blood Collection) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
The Blood Banking Devices market size was estimated at USD 42.89 billion in 2023 and is projected to reach USD 76.760 billion in 2030 at a CAGR of 8.67% during the forecast period 2023-2030.
Blood banking devices are specialized medical equipment and instruments used in the collection, processing, testing, storage and distribution of blood and its components. These devices play a crucial role in ensuring the safety and availability of blood products for various medical procedures and treatments. Blood banking devices are critical for maintaining a safe and reliable supply of blood for various medical needs, including surgeries, trauma care, cancer treatments, and more. They ensure that blood products are collected, processed, and distributed with the highest standards of quality and safety.
The blood banking devices market is expected to grow during the forecast period. This growth can be attributed to factors such as increasing demand for blood transfusions, rising incidence of blood-borne diseases, increasing number of blood donation camps and technological advancements in blood banking devices. Moreover, the growing awareness about the importance of blood donation is expected to drive the growth of the market during the forecast period.
However, there are factors that might hamper the growth of the market such as the high cost of blood banking devices and stringent regulations by governments.
The COVID-19 pandemic has had a significant impact on the blood banking devices market. The pandemic led to a decrease in the number of blood donations, as people became hesitant to donate blood due to the fear of contracting the virus. This caused a shortage of blood, which put a strain on blood banks and hospitals. Moreover, the pandemic has also led to disruptions in the supply chain for blood banking devices. This made it difficult for blood banks to get the supplies they need, which further deteriorated the market.
The blood banking devices market is expected to grow during the forecast period. This growth can be attributed to several factors. Firstly, the increasing number of surgeries and other medical procedures that require blood transfusions is driving the demand for blood banking devices. Moreover, the rising incidence of blood-borne diseases, such as HIV and hepatitis, is also driving the demand for blood banking devices. In addition, the increasing number of blood donation camps and the technological advancements in blood banking devices is expected to drive the growth of the market further during the forecast period. However, the high cost of blood banking devices and stringent regulations from authorities might hamper the growth of the market.
North America to Dominate the Market
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 8.67% during the forecasting period, 2023-2030 |
Historical Data |
2019-2021 |
Forecast Years |
2023-2030 |
Base Year |
2022 |
Units Considered |
Revenue in USD billion and CAGR from 2023 to 2030 |
Report Segmentation |
Product, mode of collection, end users, and region |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East, and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, and South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Abbott, BD, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Boston Scientific, Cardinal Health (US), Sysmex Corporation, China Biologic Products Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Hindustan Syringes & Medical Devices Ltd., Medtronic, Nova Biomedical, Ortho Clinical Diagnostics, Polymedicure, Randox Laboratories Ltd., REMI GROUP, Siemens Healthcare GmbH, Smith Medical, Terumo Corporation, Thermo Fisher Scientific, Inc. |
Available Customization |
In addition to the market data for the Blood Banking Devices Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements. |
The Blood Banking Devices Market is segmented into various segments such as product, mode of collection, end users, and region:
Based on Product
Based on Mode of Collection
Based on End Users
Based on region
The prominent players in the Blood Banking Devices market are